Characteristics

Number

Mean overall survival (months)

Confidence interval 95%

Median overall survival (months)

Confidence interval 95%

p value

Age

0.08

<60 years

11

16.5 ± 2.5

11.53 - 21.55

17 ± 4.2

8.66 - 25.33

>60 years

17

10.9 ± 1.8

7.41 - 14.35

11 ± 2.74

5.62 - 16.37

Gender

0.09

Women

2

22 ± 8

6.32 - 37.68

14

-

Men

28

12.4 ± 1.5

9.45 - 15.38

11 ± 2.1

6.83 ± 15.16

Smokers

0.09

No

3

20.3 ± 4.9

10.60 - 29.95

17 ± 2.4

12.19 - 21.80

Yes

25

12.2 ± 1.6

9.17 - 15.30

11 ± 2

7.08 - 14.91

General condition (World Health Organization)

0.004

0

9

18.8 ± 2.7

13.53 - 24.02

17 ± 4.5

8.23 - 25.76

1

11

11.8 ± 2.1

7.64 - 15.99

11 ± 2.2

6.68 - 15.31

2

1

3

-

3

-

3

7

9.3 ± 2.5

4.41 - 14.15

9 ± 1.3

6.34 - 11.56

Creatinin Clearance

0.70

<60

18

13.2 ± 1.9

9.4 - 16.9

13 ± 1

1.1 - 10.9

>60

10

13 ± 2.6

7.8 - 18.2

9 ± 1

1 - 6.9

TNM staging (T)

0.002

T1

2

7.5 ± 6.5

0 - 20.24

1

T2

1

2

2

2

T3

17

21.1 ± 1.5

10.54 - 19.2

16 ± 3.3

9.5 - 22.45

T4

8

14.9 ± 2.2

9.22 - 15

12 ± 2.8

6.4 - 17.54

TNM staging (N)

0.20

N0

20

14.1 ± 2

10.1 - 18.1

12 ± 2

7.6 - 16.4

N1

3

8 ± 1

6 - 9.96

9

-

N2

5

12.2 ± 2.3

7.6 - 16.77

14 ± 3.3

7.6 - 20.4

TNM staging (M)

0.03

M0

17

15.5 ± 2.1

11.40 - 19.53

14 ± 2.5

9.16 - 18.84

M1

11

9.5 ± 1.8

5.82 - 13.08

9 ± 3.3

2.52 - 15.47

Surgery of the tumor

0.029

No

20

10.8 ± 1.5

7.88 - 13.81

9 ± 1.7

5.71 - 12.23

Yes

8

18.7 ± 3.2

12.55 - 24.94

17 ± 6.1

4.98 - 29.01

Chemotherapy

0.22

No

14

11.1 ± 2.1

7.04 - 15.24

9 ± 3.7

1.66 - 16.33

Yes

14

15.1 ± 2.2

10.75 - 19.38

14 ± 2.8

8.55 - 19.44

type of Chemotherapy

0.03

Neoadjuvant

6

10.7 ± 1.8

7.0 - 14.2

9 ± 2.8

3.4 - 14.6

Adjuvant

6

21.2 ± 3.4

14.4 - 27.9

20 ± 4.9

10.39 - 29.6

Palliative

2

10 ± 4

2.1 - 17.8

6

-